W i O U S hormones known to be expressed in the anterior pituitary was studied by immunocytochemistry in fied, frozen tissue sections from five additional adenomas. Of the eight hormones investigated, only thyroid-stimulating hormone, luteinizing hormone, and follicle-stimulating hormone were detected, occurring in only two of the five adenomas. In contrast, granins were found in all five tumors.
Widespread Occurrence of Chromogranins /Secretogranins in the Matrix of Secretory Granules of Endocrinologically Silent Pituitary Adenomas'
To investigate the constituents of the matrix of endocrine secretory granules, we analyzed endocrinoilogidy silent ("non-functioning") human pituitary adenomas for the occurrence of the chtomograninsheaetogranins (granins), a protein family normally stored together with many different hormones. When five non-functioning pituitary adenomas were analyzed by immunoblotting using polydonal and monoclonal antibodies specific for individual members of the granin family, chromogranin A was detected in four cases and chromogranin B and secretogranin 11 were detected in all cases. The cellular distribution of the granins and of
Introduction
The chromogranins/secretogranins (referred to in abbreviated form as granins) are a family of at least three regulated secretory proteinschromogranin A (CgA), chromogranin B (secretogranin I) (CgB), and secretogranin I1 (SgI1)-which are expressed in a large number of endocrine and neuronal cells (for reviews see 6, 8, 15, 16 , and references therein). The physiological function of these proteins is still under investigation. Before secretion, they may play a role in the sorting and condensing of secretory proteins in secre-WBH was the recipient of a grant from the Deotsche Forschungs-tory granules and/or may act as reversible processing enzyme inhibitors (see 16 and references therein). Furthermore, the granins may have extracellular roles in that the intact proteins or proteolytic fragments derived from them exert biological activities on target cells (see 16 and references therein). CgA has been shown to be the precursor of pancreastatin, a peptide originally found to partially inhibit glucose-induced insulin release from the isolated pancreas (35) . In addition, a different fragment of CgA, referred to as "chromostatin," has been recently shown to inhibit regulated secretion from chromaffin cells (9, 31) .
The distribution of CgA, CgB, and SgII in normal and neoplastic endocrine and neuronal cells has been studied by several groups (for reviews see 15, 37) . It has been shown that these members of the granin family are more widely distributed than neuropeptides and peptide hormones, and that the cellular distribution of the individual granins does not always overlap but in certain tissues can be complementary (27) . Because of their widespread cellular distribution, the granins have been used as markers for normal and neoplastic endocrine and neuronal cells. In particular, these proteins may be useful in the diagnosis of neuroendocrine tumors that either do not produce or produce low concentrations of active polypeptide hormones (15, 31) . Non-functioning human pituitary adenomas, i.e., tumors from patients lacking clinical or biochemical evidence of increased plasma levels of adenohypophyseal hormones, represent an example of this type of tumor. In fact, these tumors are either completely negative for pituitary hormone production or may express and secrete the P-subunits of luteinizing hormone (LH), follicle-stimulating hormone (EH), thyroid-stimulating hormone (EH), and/or the a-subunit (aSU) common to these hormones (1, 17, 19, 25) . Using a monoclonal antibody against human CgA, DeStephano et al. (5) first found immunoreactivity for this protein in non-functioning pituitary adenomas. Although this general observation was subsequently confirmed in other studies (for review see 15) , it has been reported that not every nonfunctioning pituitary adenoma analyzed is immunoreactive for CgA (see 15 and references therein). Very little is known as to whether the CgA-negative adenomas may express other members of the granin family such as CgB and SgII; in fact, few data are available on the occurrence of CgB in pituitary adenomas (20) and no data are available for SgII. This issue is important not only from a diagnostic point of view but also with respect to the cell biology of secretory granule formation. Many non-functioning pituitary adenomas, although hormone negative, still contain secretory granules, and the molecules responsible for the formation of the dense-core matrix in the absence of hormones have not yet been identified.
Since granins show considerable species variation in parts of their sequences, antibodies raised against individual granins purified from rat and bovine tissues do not always recognize the respective human protein. Therefore, to investigate the granins in human tissues such as non-functioning pituitary adenomas, we prepared (a) monoclonal antibodies against granins purified by 2-D PAGE from the heat-stable protein fraction [which is highly enriched in granins (27) ] of a human pheochromocytoma, and (b) an antiserum against a synthetic peptide encoding the 23 carboxy-terminal amino acids of human CgB (hCgB635-657) (4).
In this study we report the presence of CgA, CgB, and SgII in non-functioning pituitary adenomas and investigate their cellular and subcellular distribution, using newly raised antibodies specific for these proteins.
Materials and Methods
TissueS. After surgical removal, tissue pieces from human pheochromocytomas, adrenal glands, and non-functioning pituitary adenomas were either frozen in liquid N2 to be processed for immunoblotting or fixed for immunoelectron microscopy (see below). Frozen tissues were crushed on dry ice into a fine powder and homogenized (1:lO) in 20 mM Tris-HCI, pH 7.4, 10 mM EIYIA, 10 pglml aprotinin (Sigma; St Louis, MO), 0.1 mM phenylmethyl sulfonylfluoride. The heat-stable protein fractions, highly enriched in CgA, CgB, and SgII. were obtained as previously described (27) .
Monoclonal Antibodies. Monoclonal antibodies against human CgA and CgB were obtained as follows. The granins were purified from human pheochromocytomas by heat treatment and rwo-dimensional PAGE (26, 27) . After electrophoresis, proteins were transferred to nitrocellulose filters and the position of CgB, CgA, and SgII was revealed by Ponceau S (Serva Fine Biochemicals, Heidelberg, FRG). Pieces ofthe nitrocellulose filter containing CgA, CgB (=7 pg each) and SgII ("2 pg) were crushed into a fine powder under liquid N2 and re-suspended in PBS, pH 7.4. The mixture, containing all three granins. was injected intraperitoneally into 6-week-old Balblc mice. One month later an intraperitoneal booster injection was performed with CgB, CgA, and SgII prepared as before. Two further booster injections were performed at 3-week intervals with 2-5 pg of each granin. After 15 days, sera from the mice were collected and tested by immunoblotting (see below). One mouse, which produced antibodies, was boosted intraperitoneally with 40 pg of protein of the heat-stable fraction of a pheochromocytoma. Two days after the last injection, spleen cells were fused with SP 2/01 myeloma cells and hybridomas were grown according to standard procedures (11.23) . Hybridoma supernatants were screened by immunoblotting and clones producing the antibodies were subcloned twice by the method of limiting dilution. Ascites fluids from the hybridoma cells were produced in pristane-treated Balb/c mice.
Antisera. An antiserum against a synthetic peptide of human CgB was produced in rabbits. For that purpose, a synthetic peptide (referred to as hCgB631-657). encoding the 23 carboxy-terminal amino acids of human CgB as deduced from its primary sequence (4). was covalently coupled to keyhole limpet hemocyanin (12) . Two hundred pg of the coupled peptide, as an emulsion with complete Freund's adjuvant, were injected per rabbit. Subsequent boosters were given at 1-month intervals. Sera were then analyzed by immunoblotting.
An antiserum previously raised against two-dimensionally pure rat SgII from PC12 cells (26) was affinity-purified on a Sepharose 4B (Pharmacia; Uppsala, Sweden) column bearing rat SgII purified from pituitary glands through the heat step and DEAE chromography as described (4). This antibody reacts with human SgII. It was also found to react weakly with human CgB. Therefore, it was always pre-absorbed with purified human CgB before use (see below).
An antiserum raised against a peptide (referred to as hSgII1-20) encoding the 20 amino-terminal amino acids of human SgII (10) was kindly provided by Dr. H.-H. Gerdes (University of Heidelberg, FRG). Rabbit antisera specific for the P-subunits of human TSH, LH, and FSH were obtained from Dr. A. Parlow (NIADDK Pituitary Hormones and Antisera Center; Harbor-UCLA Medical Center, Torrance, CA). The specificities of the latter antisera for use in immunocytochemistry were confirmed after pre-absorption with the respective antigen (see below) (36) . An antiserum against the a-subunit of human LH (for immunohistochemistry) and an antiserum against human corticotropin (ACTH) (for immunohistochemistry) were obtained from UCB Bioproducts (Brussels, Belgium). Affinitypurified antibodies against human prolactin (PIU) were kindly provided by Dr. H. Friesen (Winnipeg, Manitoba, Canada). Antibodies against human growth hormone (GH) were developed and purified as previously described (3). An antiserum against gastrin (G) [anti-gastrinl-l7. recognizing also cholecystokinin (24)] and an antiserum against highly purified porcine vasoactive intestinal polypeptide (VIP) (7) were kind gifts of Dr. J. Rehfeld (University Dept. of Clinical Chemistry, Rigshospitalet. Copenhagen, Denmark) and Dr. J. Frahrenkrug (Bispebjerg Hospital, Copenhagen, Denmark), respectively, and were obtained from Dr. L. Scopsi (Istituto Tumori, Milan, Italy). An antiserum against synaptophysin was from Biometra (Gottingen, FRG).
As a control, pituitary adenomas secreting prolactin. GH, ACTH, or glycoprotein hormones were immunostained using the above-mentioned antibodies and found to be immunoreactive. In addition, immunoreactivity for gastrin was found in two ACTH-secreting tumors immunostained with the anti-gastrin antiserum, and immunoreactivity for VIP was found in two ACTH-and one Pasecreting tumor immunostained with the anti-VIP antiserum.
Immunoblotting. For immunoblotting, the heat-stable proteins from human tissues and tumors were separated by SDS-PAGE (26) using a miniprotean I1 slab cell (Bio-Rad Laboratories; Richmond, CA) and transferred to nitrocellulose filters. The filters were incubated for 18 hr at 4'C in PBS containing 8% bovine serum albumin (immunoblotting buffer), followed by a further incubation for 2 hr at room temperature in immunoblotting buffer containing 0.3% Triton X-100 in which the ascites fluids, the rabbit antisera, or the pre-immune IgG were appropriately diluted. In some cases, filters were incubated in immunoblotting buffer-Triton containing either the anti-hCgB63s457 antiserum or the anti-hSgII1-20 antiserum and the corresponding synthetic peptide. After several washes in PBS containing 0.3% Triton X-100, filters were incubated for 45 min with peroxidase conjugated either to goat anti-mouse IgG and IgM antibodies or to goat antirabbit IgG antibodies (Jackson Immunoresearch Laboratories; Avondale, PA) diluted in immunoblotting buffer-Triton. They were then washed with PBSTriton and developed with 0.5 m g / d 3,Y-diaminobenzidine and 0.03% H202 in 50 mM Tris-HC1, pH 7.5.
Antibody Pre-absorption. To eliminate the crossreactivity of the antirat SgII antibodies with human CgB, the antibodies were pre-absorbed with CgB purified from the heat-stable proteins of human adrenal glands by preparative SDS-PAGE. After electrophoresis, proteins were transferred to nitrocellulose filters and stained with Ponceau S. Filter pieces containing pure CgB (4) were excised from the filters and then used for pre-absorption as described (2). Briefly, filter pieces with either =7 or =35 pg of pure human CgB were incubated at 4°C in either 0.1 ml of PBS, pH 7.3, 1% bovine serum albumin, and 0.1 M glycine (PBG buffer) containing 1.5 pg of anti-rat SgII antibody, or in 7 ml of immunoblotting buffer containing 10 pg of anti-rat SgII antibody, respectively. After 16 hr the incubation buffers were collected and used for immunolabeling of either blots or frozen tissue sections. The anti-hCgB63~417 antiserum and the anti-PFSH antiserum were diluted 150 and 1:15, respectively, in 0.1 ml of PBG buffer and were pre-absorbed, when indicated, with either 8 pg of peptide hCgB631-657 or 10 pg of human flFSH.
Immunocytochemistry. Immediately after surgical removal, small pieces of adenoma tissue were fixed for 2 hx at 4'C with 4% paraformaldehyde and 0.2% glutaraldehyde in 0.1 M phosphate buffer @H 7.3), passed through a series of increasing concentration sucrose solutions, mounted on specimen holders, and finally frozen in Freon (2, and references therein).
For immunofluorescence. frozen tissue sections (=1 pm) were cut, mounted on gelatin-coated glass microscopy slides, and immunostained with specific antibodies, followed by goat anti-mouse IgG or anti-rabbit IgG immunoglobulins conjugated to rhodamine as previously described in detail (3.28).
For double immunoelectron microscopy, ultra-thin frozen sections (~100 nm) were cut at -100°C on an Ultra-cut "E" microtome (Reichert-Jung; Wien, Austria) equipped with an FC4 cryochamber, transferred to formvarcoated nickel grids, and then subjected to immunolabeling as described (2.13). Briefly, the ultra-thin sections were incubated at 37'C with the first antibody for 1 hr, stained for 45 min with either protein A or goat antimouse IgG conjugated to 5-nm gold particles Uanssen Life Sciences; Olen, Belgium), both appropriately diluted in PBG buffer, and rinsed with the same buffer. The ultra-thin sections were then incubated with the second antibody for 1 hr and stained for 45 min with 15-nm gold particles conjugated to either goat anti-mouse IgG or protein A, followed by extensive washes with PBG buffer and PBS. When double immunolabeling was performed with different sizes of gold particles conjugated to protein A, grids were incubated for 15 min with unconjugated protein A (0.05 mg/ml in PBS) before the incubation with the second antibody. All ultra-thin sections were f d l y fixed in 1% glutaraldehyde and then in 1% osmium tetroxide, stained with uranyl acetate, dehydrated. and embedded in LR White resin. Samples were examined with a Philips 400 electron microscope (Philips Industries; Eindhoven, The Netherlands).
Results

Characterization of Antibodies Against Human Granins
Characterization of hybridomal ascites fluids and the rabbit antiserum by immunoblotting of the heat-stable proteins of adrenal gland and pheochromocytoma revealed that the dif%rent antibodies specifically recognized either CgA, CgB, or SgII (Figure 1 ). Two monoclonal antibodies (MAb) against human CgA were isolated, referred to as 169-E10-4 and 197-13 ( Figures 1A and lB , respectively). In adrenal gland, MAb 169-E104 immunostained two prominent bands of ~7 5 and 70 KD (Figure lA, Lane AG) , which correspond to human CgA (18, 30) . When the heat-stable proteins of a pheochromocytoma ( Figure IA, Lane PH) were immunostained, the antibody immunolabeled two major bands of =78-67 KD as well as a number of bands of lower molecular weight, which represent proteolytic products of CgA. A similar immunostaining pattern was obtained when the heat-stable proteins of the same pheochromocytoma were labeled with MAb LK2HlO (data not shown), a well-characterized antibody against human CgA (21) . In adrenal gland and in the pheochromocytoma (Figure lB AG and PH). The antiserum raised against hCgB635-657 showed an immunostaining pattern different from that of MAb 67-C7-2. Anti-hCgB635-6s7 antiserum stained the band corresponding to mature CgB and a few bands of lower molecular weight, but did not immunoreact with the polypeptide of 110 KD (Figure ID , Lanes AG and PH). This is in agreement with the data obtained by Schmid et al. (29) . An antiserum raised against hSgII1-20 (Gerdes et al., unpublished) recognized a band of 86 KD as well as other bands of lower molecular weight ( Figure 1E. lanes AG and PH) . The immunostaining pattern obtained with the anti-hSg111-20 antiserum was similar to that obtained with an antibody previously raised against rat SgII (27) (Figure lF , Lanes AG and PH). As a control for the specificity of the immunolabeling obtained with the different monoclonal antibodies and antisera, blots of heat-stable proteins of the pheochromocytoma were stained with either pre-immune IgGs under the respective conditions ( Figures 1A, IC , and IF, con), or the anti-hCgB635-657 or the anti-hSgII1-20 antiserum preabsorbed with the corresponding synthetic peptides ( Figures 1D  and 1E, con) .
When the antibodies newly raised in this study were investigated by immunoblotting for their ability to recognize the respective gmnins of other species, it was found that only the anti-hCgB635-657 antibody recognized CgB of other species, i.e., bovine and rat CgB. In contrast, the anti-CgA MAb 169-E104 and 197-13 and the anti- CgB MAb 67-C7-2 recognized neither bovine, mouse, nor rat CgA and CgB, respectively (data not shown).
Characterizgtion of Granins in Human Pituitary Adenomas by Immunoblotting
Tissue from five pituitary adenomas unassociated with clinical evidence for hormone excess were used in this study. Equal amounts of heat-stable proteins from the tumors were separated by SDS-PAGE, transferred to nitrocellulose filters, and inmunostained using the antibodies described in Figure 1 . Bands corresponding to CgA, CgB. and SgII were immunodetected in four cases (Figures 2A-2D , Lanes 1-4). One case showed high immunoreactivity for CgB and SgII but no immunoreactivity for CgA (Figures 2A-2D . Lanes 5). The immunostaining pattern obtained for the non-functioning pituitary adenomas differed from that obtained for adrenal gland and pheochromocytoma. For example, in the pituitary adenomas, the 110 KD band, which represents the major proteolytic product of CgB in adrenal gland and pheochromocytoma (compare Figure  IC) , was not detected to any significant extent using MAb 67-C7-2 against human CgB, indicating that the proteolytic processing of CgB in the adenomas differed from that in the adrenal gland and the pheochromocytoma.
Immunohistochemistry
The cellular localization in non-functioning pituitary adenomas (Cases 1-5, Table 1 ) of the granins as well as that of different polypeptide hormones and synaptophysin, a widespread neuroendocrine marker (37) , was studied in frozen tissue sections by immunocytochemistry. At least two of the granins' proteins were immunodetected in all five tumors examined. In three cases (1,3,4, Table I ), all three granins were immunodetected ( Figures 3A, 3B , 3D, 3E, 4A, and 4C). In Case 2, immunoreactivity for SgII and CgB was detected in all tumor cells, whereas only a few of the cells were positive for CgA (Table 1 ; Figures 3C and 4D ). This result was in line with that obtained by immunoblotting, which revealed no detectable level of CgA in the heat-stable proteins prepared from unfixed tissue of this adenoma (see Figure 2D , Lane 5 ) . In an additional case (5, Table 1 ). only CgB and SgII (data not shown), but not CgA ( Figure 4B ), were immunodetected. In all cases, granin immunoreactivity exhibited a punctate appearance consistent with their localization in secretory granules (Figures 3 and 4 ). Some differences in the immunofluorescence pattern for SgII and CgA were observed in one case, Case 3 ( Figures  3E and 4A) ; here, CgA immunoreactivity appeared to be more clustered under the plasma membrane than the SgII immunoreactivity.
When inmunolabeling was performed for the aSU, PLH. PFSH, or PSH, the subunits of glycoprotein hormones were immunodetected in two out of five cases (Table l) , the immunofluorescence pattern ( Figure 4F ) being similar to that for granins. On the contrary, when antibodies against ACTH, PRL, GH, VIP, and gastrin were used, immunolabeled cells were not detected in any of the five tumors (Table 1) . Immunoreactivity for synaptophysin was observed in all five adenomas, showing a staining pattern different from that of the granins and the glycoprotein hormones ( Figure 4E ). Table  1 ); only Case 2 was investigated by both immunohistochemistry (see Table 1 ) and imlecular weight standards (MW) are indicated. Immunostaining was not detected when tissue sections were immunolabeled with either pre-immune mouse IgG or normal rabbit serum (data not shown).
DoubLe Immunoekctron Microscopy
To study the subcellular localization of the granins, ultra-thin frozen sections from adenomas were double immunolabeled using specific antibodies and protein A or anti-mouse IgG antibodies conjugated to gold particles of different sizes.
In all five adenomas, the granins and, if present, the three glycoprotein hormones were localized in the dense core matrix of secretory granules, which had the relatively small size (z100-150-nm diameter) typical of secretory granules in non-functioning pitu- itary adenomas. When double immunolabeling was performed using MAb 169-E104 against CgA and anti-hCgB631-617 antiserum, immunolabeling for CgA and CgB was detected in secretory granules where both proteins mainly co-localized. Only a few secretory granules appeared to be immunolabeled for either CgA or CgB ( Figures SA-SC) . When double immunolabeling was performed using anti-CgB635-657 antiserum and anti-rat SgII antibodies, CgB and SgII either co-localized in secretory granules or were detected in different secretory granules ( Figures 5D and 5E ). When double immunolabeling was performed with the MAb against CgA and anti-SgII antibodies, the results were similar to those obtained for CgB and SgII, CgA and SgII being found either in the same or in different secretory granules ( Figures 5F and 5G) . The segregation of CgA and SgII was especially evident in Case 3, where secretory granules mainly positive for CgA and secretory granules mainly positive for SgII were detected (Figure SF) . In this adenoma, immunoreactivity for CgB and CgA was mainly co-localized (data not shown).
When double immunolabeling of ultra-thin frozen sections of Case 2 was performed for SgII and glycoprotein hormone subunits, SgII and the aSU, PLH, P S H , or PFSH were found to mainly colocalize in secretory granules (Figures 6A-6D) . The same result was obtained when double immunolabeling was performed for glycoprotein hormones and CgB or CgA ( Figure 6E , and data not shown).
To investigate the specificity in immunoelectron microscopy of the antibodies raised against hCgB635-657 and PFSH, the anti-hCgB635-657 antiserum and the anti-DFSH antiserum were preabsorbed with the synthetic peptide hCgB635457 and pure human PFSH, respectively. When the pre-absorbed antibodies were used to single immunolabel ultra-thin frozen sections, no significant immunolabeling for CgB or PFSH was detected ( Figures 7A and  7C ). As further controls, when ultra-thin frozen sections were single immunolabeled with pre-immune mouse IgG or normal rabbit serum instead of the specific antisera or monoclonal antibod- (Figures 7B and 7D) . Finally, when one of the two primary antisera was omitted in double immunolabeling, only one type of gold particle (the appropriate one) was detected (data not shown).
Discussion
Previous immunohistochemical studies have shown that many, but not all, human non-functioning pituitary adenomas stain positively for CgA and CgB (20, 22, 34) . We show now the presence of SgII, as well as CgB and CgA, in non-functioning adenomas using novel specific antibodies raised against either these proteins purified from human neuroendocrine tumors or synthetic peptides corresponding to different regions of the human CgB and SgII molecules. Immunoelectron microscopy of ultra-thin frozen sections of non-functioning adenomas revealed the presence of the granins in small secretory granules. To our knowledge, this is the first report showing that at least two members of the granin family are present in secretory granules of every non-functioning human pituitary adenoma analyzed. This not only demonstrates that the granins, and in particular CgB and SgII, can be used as markers in the diagnosis of non-functioning adenomas but also has important implications for the biogenesis of the dense-core matrix of secretory granules in the absence of hormones, as will be discussed below.
Dzfferential Expression of CgA, CgB, and SgII in Non-functioning Adenomas
We examined nine different non-functioning pituitary adenomas diluted 1:25) , anti-DFSH antiserum (diluted 1:25) , anti-!3TSH antiserum (diluted 1:25) , and antia-subunit antiserum (diluted 1500). In A-D, Sgll (large gold particles) and the subunits of glycoprotein hormones (small gold particles) mainly co-localize in secretory granules. In E, CgB (large gold particles) co-localize with the a-subunit (small gold particles) in secretory granules. M, mitochondria. Original magnifications: A x 57,000; B x 59,000; C x 58.000; D x 49,000; E x 62,000. Bars = 0.1 wm. using immunoblotting and/or immunocytochemical techniques. Many of these adenomas (seven out of nine) expressed all three of the granins. However, other adenomas mainly synthesized only two members of the granin family, SgII and CgB. These results extend previous observations of other authors who, using antibodies against CgA, found no immunoreactivity for CgA in some non-functioning adenomas (20,22,34) . What might be the mechanism underlying the differential expression of individual members of the granin family in non-functioning pituitary adenomas reported here? We have recently shown that in cow anterior pituitary all three granins are present, together with the glycoprotein hormones, in virtually all secretory granules of thyrotrophs and gonadotrophs and in the small, less electron-dense secretory granules of somatomammotrophs (2). The latter cells, which produced at least seven regulated secretory proteins-PRL. GH, TSH, LH, CgA, CgB, and SgII-and stored them in three different populations of secretory granules (2), may represent stem cells, multipotential for differentiation in that they are progenitors of distinct monohormonal cells. It is not clear if non-functioning pituitary tumors derived from stem cells or differentiated cells. Recently, it has been reported that many human non-functioning pituitary adenomas are monoclonal (14). i.e., derived from a single mutated cell, and a somatic mutation may be at the basis of pathogenesis. It is not clear, however, if this mutation happens in stem cells or in differentiated cells. Whatever the origin of non-functioning pituitary adenoma cells may be, the lack of CgA in some of these tumors may reflect a (de)differentiation process in which the expression of CgB and SgII is maintained. Data are available to envision how differential gene expression of the individual members of the granin family could occur. For example, it has been demonstrated that GnRH stimulates CgB but not CgA mRNA levels in human pituitary adenomas (33). Therefore, dfierential expression of cell surface receptors that are involved in regulating the expression of some, but not other, members of the granin family may contribute to the differential expression of the granins observed here.
Granins and the Formation of the Dense-core Matrix of Endocrine Secretory Granules in the Absence of Pol'ypeptide Hormones
With respect to the biogenesis of endocrine secretory granules, the most striking observation of the present study was the presence of the granins in all non-functioning pituitary adenomas analyzed, all of which contained dense-core secretory granules but many of which showed no detectable immunoreactivity for any of the polypeptide hormones tested. In fact, the appearance of the dense-core granule matrix was similar irrespective of whether or not the glycoprotein hormones were present. This suggests that the granins have a central role in the formation of the dense-core matrix. The observation (32) that neoplastic cells from a medullary thyroid carcinoma and a pancreatic islet cell carcinoma express CgA but not the expected hormones, calcitonin and insulin, respectively, is consistent with this suggestion. Our finding that some hormonenegative secretory granules contained only SgII but not CgA or CgB raises the possibility that a single member of the granin family may be sufficient for the formation of the dense-core matrix of an endocrine secretory granule.
